Acura Pharmaceuticals, Inc. Announces Investigational New Drug Application
By Frontier India Pharmacetuicals News | March 16th, 2010 | Category: Latest, New Medicine News | No Comments »Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application (“IND”) filed with the U.S. Food and Drug Administration (“FDA”) for a benzodiazepine product candidate utilizing our Aversion® Technology. The primary active ingredient in this product candidate is intended for the treatment of anxiety disorders.
Aversion® Technology is a [...]